Skip to main content
. 2022 Jun 24;17(6):e0270141. doi: 10.1371/journal.pone.0270141

Table 1. Patient characteristics.

Characteristic Overall High bicarbonate Normal bicarbonate Low bicarbonate
n = 60 n = 13 n = 30 n = 17
Age, years 72 (64, 78) 74 (71, 83) 72 (65, 78) 70 (61, 78)
Male, n (%) 36 (60%) 5 (38%) 19 (63%) 12 (71%)
BMI 25.0 (22.3, 28.7) 25.1 (22.4, 25.7) 25.3 (23.4, 28.9) 22.3 (20.9, 29.5)
Treatment limitation 16 (27%) 3 (23%) 7 (23%) 6 (35%)
Hypertension, n (%) 34 (57%) 6 (46%) 17 (57%) 11 (65%)
Diabetes, n (%) 17 (28%) 4 (31%) 8 (27%) 5 (29%)
Heart disease, n (%) 9 (15%) 1 (7.7%) 3 (10%) 5 (29%)
Dementia, n (%) 4 (6.7%) 2 (15%) 0 (0%) 2 (12%)
Chronic lung disease, n (%) 4 (6.7%) 0 (0%) 3 (10%) 1 (5.9%)
Body temperature, °C 38.1 (37.4, 38.5) 38.1 (37.9, 38.6) 37.7 (37.0, 38.4) 38.3 (38.2, 38.5)
Respiratory rate, bpm/min 24 (22, 31) 22 (20, 24) 24 (22, 28) 30 (25, 34)
SpO2, % 92 (88, 94) 91 (88, 93) 92 (89, 94) 93 (91, 94)
FiO2 0.32 (0.28, 0.50) 0.28 (0.28, 0.32) 0.30 (0.28, 0.50) 0.36 (0.28, 0.60)
SOFA score 3 (2, 4) 3 (2, 3) 2 (2, 3) 4 (2, 6)
Respiratory sub-SOFA score 2 (2, 2) 2 (2, 2) 2 (2, 2) 2 (2, 2)
Renal sub-SOFA score 0 (0, 0) 0 (0, 0) 0 (0, 0) 0 (0, 1)
C-reactive protein, mg/L 7.0 (4.4, 12.5) 7.9 (2.7, 13.2) 7.5 (3.4, 14.0) 6.6 (4.8, 8.0)
Ferritin, ng/mL 570 (310, 934) 369 (185, 410) 699 (365, 969) 535 (261, 958)
Creatinine, mg/dL 0.8 (0.7, 1.1) 0.7 (0.6, 1.0) 0.8 (0.7, 0.9) 1.1 (1.0, 1.6)
Bicarbonate, mEq/L 22.5 (21.6, 24.5) 24.7 (23.0, 27.4) 23.1 (22.1, 24.3) 20.4 (17.8, 22.0)
Potassium, mEq/L 3.8 (3.3, 3.9) 3.5 (3.3, 3.8) 3.8 (3.4, 3.9) 3.8 (3.4, 3.9)
Medications
ACE inhibitors, n (%) 3 (5.0%) 1 (7.7%) 1 (3.3%) 1 (5.9%)
ARB, n (%) 16 (27%) 3 (23%) 6 (20%) 7 (41%)
Aldosterone blockers, n (%) 2 (3.3%) 1 (7.7%) 0 (0%) 1 (5.9%)
Renin blockers, n (%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Loop diuretics, n (%) 7 (12%) 2 (15%) 2 (6.7%) 3 (18%)

Statistics presented: Median (IQR) or n (%)

BMI; Body Mass Index, SpO2; peripheral oxygen saturation, FiO2; fraction of inspiratory oxygen, SOFA; peripheral oxygen saturation, ACE; angiotensin-converting enzyme, ARB; angiotensin receptor antagonist.